Education
About Us
Working with TipRanks
Follow Us
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
69C Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
€105.52→€10.55
Hold
-28.75%
Downside
Downgraded
06/12/24
Cara Therapeutics downgraded to Hold from Buy at CanaccordCara Therapeutics downgraded to Hold from Buy at Canaccord
Piper Sandler
€10.55
Hold
-28.75%
Downside
Reiterated
05/14/24
Piper Sandler Sticks to Their Hold Rating for Cara Therapeutics (CARA)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
€105.52→€10.55
Hold
-28.75%
Downside
Downgraded
06/12/24
Cara Therapeutics downgraded to Hold from Buy at CanaccordCara Therapeutics downgraded to Hold from Buy at Canaccord
Piper Sandler
€10.55
Hold
-28.75%
Downside
Reiterated
05/14/24
Piper Sandler Sticks to Their Hold Rating for Cara Therapeutics (CARA)
Best Analysts Covering Tvardi Therapeutics
Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
69C Analyst Recommendation Trends
Rating
Apr 24
May 24
Jun 24
Aug 24
Dec 24
Strong Buy
7
10
7
5
0
Buy
0
0
0
0
0
Hold
0
1
5
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
11
12
11
7
Each month's total comprises the sum of three months' worth of ratings.
69C Stock Forecast FAQ
What is DE:69C’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:69C’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:69C, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Tvardi Therapeutics a Buy, Sell or Hold?
Currently, no data Available
What is Tvardi Therapeutics’s share price target?
Currently, no data Available
What do analysts say about Tvardi Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Tvardi Therapeutics?
To buy shares of DE:69C, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.